Stephen Sherwin, Director at Biogen, holds 11.32K shares in Biogen (Ticker: BIIB), holds 10.67K shares in Neurocrine (Ticker: NBIX), holds 0.00 shares in Neon Therapeutics (Ticker: NTGN). Most recently, Stephen Sherwin Sold ― shares of Biogen on Mar 10, 2025 for an estimated value of 1.31M.
Stephen Sherwin latest transaction was an Informative Sell of $1.31M.
What was Stephen Sherwin's most profitable transaction?
Stephen Sherwin’s most profitable transaction was an Informative Buy of VSTM stock on December 29, 2014. The return on the trade was -78.10%.
What is Stephen Sherwin's role in Biogen?
Stephen Sherwin's role in Biogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.